Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
Circulating MicroRNAs as a Tool for Diagnosis of Liver Disease Progression in People Living with HIV-1.
Next-generation point-of-care testing in pediatric human immunodeficiency virus infection facilitates diagnosis and monitoring of treatment.
Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome.
T Cell Responses in Chronic HIV Infection Are Associated With Virus Control and Antibody Isotype Switching to IgG.
Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells.
Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19.
Comparison between mid-nasal swabs and buccal swabs for SARS-CoV-2 detection in mild COVID-19 patients.
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
What Should Be Learned From Repurposed Antivirals Against SARS-CoV-2?
Modulation of the autophagic pathway inhibits HIV-1 infection in human lymphoid tissue cultured ex vivo.